Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1124-1132. doi: 10.1111/jdv.15475. Epub 2019 Apr 8.
Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients' health and well-being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that 'long-term control of eczema' is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema.
To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term.
Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups.
Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty-two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered.
This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions.
特应性皮炎(也称为湿疹)是一种慢性炎症性皮肤病,常影响患者的健康和福祉。特应性皮炎结局测量协调倡议(HOME)建议,在所有持续时间为 3 个月或更长时间的临床试验中,都应测量“湿疹的长期控制”。然而,对于患有特应性皮炎或治疗特应性皮炎的患者、护理人员和临床医生来说,湿疹控制意味着什么,相关报道却很少。
(i)了解患者、护理人员和临床医生对湿疹控制的理解,(ii)探索长期评估湿疹控制的不同方法的可行性和可接受性。
在线焦点小组探讨了英国、美国、荷兰、法国、瑞典和日本患者/护理人员的经验,并进行了一项国际在线调查,以收集临床医生的意见。使用框架方法分析焦点小组,使用主题分析方法分析调查数据。将所有发现整合到一个理论框架中,以创建跨这些不同群体的总体主题。
共进行了 8 次针对患者(16 岁及以上)和 8 次针对儿童护理人员的在线焦点小组(N=97)。62 人参加了调查。湿疹控制被描述为一个多方面的结构,涉及疾病活动的变化、疾病的治疗和管理以及心理、社会和身体功能。患者/护理人员的测量允许进行个人报告和频繁测量,而临床医生的测量被认为主观性较小。应考虑患者/护理人员的负担以及分析和解释数据的问题。
本研究为判断评估临床试验中湿疹控制的测量工具/方法的内容有效性和可行性奠定了基础。这种在线的国际定性研究方法是资源有限的核心结局集开发者如何在国际基础上与多个利益相关者群体接触,以告知共识会议讨论的一个范例。